Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilo Jimenez

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Thyroid : Official Journal of the American Thyroid Association|September 28, 2016
Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationJian Yu Xu, Elizabeth G Grubbs, Steven G Waguespack, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 20, 2023
Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer RegistryVania Balderrama-Brondani, Allison M Griffin, Taylor J Owen, et al.
Journal of Cancer Research and Clinical Oncology|July 17, 2019
Genetic profiling as a clinical tool in advanced parathyroid carcinomaMerve Kutahyalioglu, Ha T Nguyen, Lily Kwatampora, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or ParagangliomaDaniel A Pryma, Bennett B Chin, Richard B Noto, et al.
The American Journal of Cardiology|April 22, 2015
Succinate dehydrogenase gene mutations in cardiac paragangliomasVictoria L Martucci, Abbas Emaminia, Jaydira del Rivero, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinomaMouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2016
Bone Metastases and Skeletal-Related Events in Medullary Thyroid CarcinomaJian Yu Xu, William A Murphy, Denái R Milton, et al.
Annals of Surgical Oncology|February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or ParagangliomaMinerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2022
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center ExperienceMarilyne Daher, Jeena Varghese, Stephen K Gruschkus, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Thyroid : Official Journal of the American Thyroid Association|September 28, 2016
Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationJian Yu Xu, Elizabeth G Grubbs, Steven G Waguespack, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 20, 2023
Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer RegistryVania Balderrama-Brondani, Allison M Griffin, Taylor J Owen, et al.
Journal of Cancer Research and Clinical Oncology|July 17, 2019
Genetic profiling as a clinical tool in advanced parathyroid carcinomaMerve Kutahyalioglu, Ha T Nguyen, Lily Kwatampora, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or ParagangliomaDaniel A Pryma, Bennett B Chin, Richard B Noto, et al.
The American Journal of Cardiology|April 22, 2015
Succinate dehydrogenase gene mutations in cardiac paragangliomasVictoria L Martucci, Abbas Emaminia, Jaydira del Rivero, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinomaMouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2016
Bone Metastases and Skeletal-Related Events in Medullary Thyroid CarcinomaJian Yu Xu, William A Murphy, Denái R Milton, et al.
Annals of Surgical Oncology|February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or ParagangliomaMinerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2022
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center ExperienceMarilyne Daher, Jeena Varghese, Stephen K Gruschkus, et al.
Pageof 15